Autoimmune Disease
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Netherlands-based Argenx Raises $1.1 Billion in Global Offering Following Success in Clinical Trials
2023-07-23
Vallon and GRI Bio Strike a Merger Deal, Joining Forces for Innovative NKT Cell Regulators
2022-12-14
LATEST
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15